The multifaceted compound, Cannabidiol (CBD), has been the subject of extensive scientific research due to its potential therapeutic benefits and non-psychoactive nature. A recent analysis published in the NCBI (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489340/), examines the pharmacological properties, safety, efficacy, and regulatory status of CBD. In this summarized review, we provide a synthesis of Read more…
Study Overview An emerging treatment approach for glioblastoma multiforme (GBM), one of the most aggressive and lethal forms of brain cancer, has been examined in a pivotal study. This approach involves the local delivery of cannabinoid-loaded microparticles, which has demonstrated significant efficacy in inhibiting tumor growth within a murine xenograft Read more…
Diabetic peripheral neuropathic pain (DPNP) represents a significant clinical challenge, often leading to severe and chronic pain in individuals with diabetes. A study titled “Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain” provides insights into the potential therapeutic effects Read more…
The study published in the Translational Psychiatry journal provides valuable insights into the cognitive effects of cannabinoids, specifically delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Acute administration of these substances has raised both medical interest and public health concerns due to their contrasting effects on cognition and mental health. Study Overview The Read more…
Recent studies, including those documented in the seminal research article “Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine,” have shed light on the benefits of cannabidiol (CBD) for those suffering from migraine. This comprehensive analysis provides vital insights into how CBD interacts with the bodyβs biochemical Read more…
Recent studies have highlighted the possibility that cannabidiol (CBD), a non-psychoactive compound found in cannabis, may offer beneficial effects for the cardiovascular system. Research published in the National Center for Biotechnology Information (NCBI) delves into the therapeutic potential of CBD for various cardiovascular disorders. The paper titled “Is the cardiovascular Read more…
Study Summary: Understanding the Acute Effects of Cannabis with and Without Cannabidiol (CBD) A recent randomised, double-blind, placebo-controlled, crossover experiment investigated the acute effects of cannabis on adults and adolescents, with a particular focus on formulations with and without cannabidiol (CBD). The study, published by researchers, provides a comprehensive analysis Read more…
Lennox-Gastaut syndrome (LGS) is a severe and challenging-to-treat form of epilepsy. But there’s promising news for patients and caregivers seeking relief. A detailed investigation published in Frontiers in Neurology has shed light on the impact and timing of cannabidiol (CBD) treatment for LGS. The research examined data from two pivotal, Read more…
Alcohol use disorder (AUD) is a prevalent and debilitating condition, encompassing a spectrum of behaviors including addiction to alcohol. Traditional treatments for AUD include behavioral therapies and a small selection of pharmaceuticals, yet these approaches often fall short in efficacy and accessibility. Given this treatment gap, there has been growing Read more…
New research published in European Journal of Pharmacology sheds light on the therapeutic potential of cannabidiol (CBD) for heart regeneration following myocardial infarction, commonly known as a heart attack. The study, titled “Cannabidiol represses miR-143 to promote cardiomyocyte proliferation and heart regeneration after myocardial infarction”, reveals a promising mechanism through Read more…